drugset / Trial / NCT06762600

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects

NCT06762600

Phase 1 Completed 102 enrolled Fujian Shengdi Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-4729 injection in healthy subjects.

Timeline

Start
2025-01-16
Primary completion
2026-03-12
Completion
2026-03-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-4729 Unknown Subcutaneous
Subject HRS9531 Unknown
Background Acetaminophen Small molecule

Indications